Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NorQuin is a vertically integrated plant science and food technology company specializing in the development and production of quinoa-based solutions. Headquartered in Saskatoon, Canada, the company is a pioneer in adapting quinoa for large-scale production in Northern climates through proprietary plant breeding and agricultural research. Their business model encompasses the entire supply chain, from seed development and farming to advanced mechanical processing and global ingredient distribution. NorQuin provides a diverse range of products, including whole grains, flours, flakes, and high-protein concentrates, catering to the growing demand for plant-based, non-GMO, and gluten-free foods. In 2022, the company was acquired by AB Mauri, a division of Associated British Foods, to enhance its portfolio of specialty grains and functional plant-based ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NorQuin.